CI
COGT icon

Cowen Inc’s Cogent Biosciences COGT Stock Holding History

Cowen Inc’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$2.15M Buy
205,201
+852
+0.4% +$11.3K 0.15% 106
2019
Q1 		$3.59M Hold
204,349
– – 0.39% 53
2018
Q4 		$3.6M Buy
204,349
+41,825
+26% +$1.24M 0.4% 57
2018
Q3 		$6.7M Buy
162,524
+17,210
+12% +$970K 0.61% 43
2018
Q2 		$8.34K Buy
+145,314
New +$6.98M 0.35% 47

Other funds holding COGT

AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cowen Inc's COGT Position: Q2 2019 in Review

Cowen Inc increased its Cogent Biosciences (COGT) stake by 0.42% in Q2 2019, buying an estimated $11.3K and bringing the position to 205,201 shares worth $2.15M. The position accounts for 0.15% of the portfolio, ranked #106.

Cowen Inc first reported a position in COGT in Q2 2018 and has held it in 5 quarters since. The position peaked at $6.7M in Q3 2018. 39 funds tracked by Wall St. Rank hold COGT as of Q2 2019.

  • Cowen Inc held 205,201 shares of Cogent Biosciences worth $2.15M as of Q2 2019.
  • Cowen Inc bought 852 Cogent Biosciences shares in Q2 2019, an estimated $11.3K.
  • Cogent Biosciences made up 0.15% of Cowen Inc's portfolio in Q2 2019, its #106 holding.
  • Cowen Inc first reported a position in Cogent Biosciences in Q2 2018 and has held it in 5 quarters since.
  • Cowen Inc's Cogent Biosciences position peaked at $6.7M in Q3 2018.
  • 39 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.